Rehab Research Rendezvous: Join the Hybrid Health Chat
Published Date: 3/12/2026
Notice
Summary
The Eunice Kennedy Shriver National Institute of Child Health & Human Development is hosting a hybrid meeting on December 7-8, 2026, about medical rehabilitation research. Anyone interested can join in person or online, share ideas, or even speak at the meeting. This is a great chance for researchers, patients, and advocates to get involved and learn about new research and policies—no registration needed!
Analyzed Economic Effects
4 provisions identified: 3 benefits, 1 costs, 0 mixed.
Hybrid public meeting — no registration
The National Advisory Board on Medical Rehabilitation Research will hold a hybrid public meeting on December 7-8, 2026 (Dec 7: 10:00 a.m. to 3:00 p.m.; Dec 8: 10:00 a.m. to 2:00 p.m.) at 6710 B Rockledge Drive, Bethesda, MD, and online via NIH Videocast (https://videocast.nih.gov/). Registration is not required to attend in person or virtually.
How to give written or oral comments
Any member of the public may file written comments by sending a statement with name, address, telephone number, and affiliation to the listed Contact Person. To present oral comments, you must notify the Contact Person at least 10 days before the meeting, submit a letter of intent and brief description, and (if accepted) presentations may be limited to five minutes with only one representative per organization.
Accommodations for attendees with special needs
Individuals who plan to attend in person or view the virtual meeting and need special assistance or reasonable accommodation should notify the Contact Person listed in advance of the meeting.
On-campus entry and ID requirements
Visitors attending the meeting on campus will be subject to NIH security procedures: visitor vehicles (including taxis and shuttles) will be inspected before being allowed on campus, and visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver's license, or passport) and state the purpose of their visit.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13612 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review and decide on important health research grant applications. These meetings keep sensitive info private to protect personal and commercial secrets. Researchers applying for grants and the public can expect no changes in funding timing or amounts, just careful, confidential reviews.
2026-13479 — Government Owned Invention Available for License: Chimeric VLP Vaccines To Prevent HTLV-1 Infection
The National Cancer Institute has created a new vaccine to stop HTLV-1, a virus that can cause serious diseases like leukemia. Right now, no vaccine exists, so this invention could protect millions, especially in underserved areas. They’re looking for partners to help develop and license this promising vaccine, which could save lives and reduce healthcare costs in the near future.
2026-13480 — Government Owned Invention Available for License: A Conserved Viral Peptide for Use in Cancer Immunotherapy
The National Cancer Institute has created a special viral peptide that could help prevent and treat a serious liver cancer called HCC. This new discovery might lead to a vaccine or therapy that boosts the immune system to fight cancer better. Researchers and companies interested in developing this treatment can now license the technology, opening doors for faster progress and potential health benefits worldwide.
2026-13311 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review grant applications and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants or contracts should watch these dates closely, as funding decisions could impact their projects and budgets.
2026-13337 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on July 24, 2026, to review and evaluate important grant applications related to cancer, imaging, eye diseases, and reproductive health. These meetings protect private info and trade secrets, so they’re not open to the public. Researchers and organizations applying for grants should note the dates as these reviews impact funding decisions.
2026-13244 — The Federal Demonstration Partnership; Phase VIII Notice
The Federal Demonstration Partnership (FDP) is inviting colleges, universities, research groups, and hospitals that get federal research money to join its Phase VIII starting in 2027. This phase will keep testing new ways to make research funding and rules easier and faster. Applications are due by September 15, 2026, with the program running through the end of 2032.
Previous / Next Documents
Previous: 2026-04859 — Department of Defense Wage Committee; Notice of Federal Advisory Committee Meeting
The Department of Defense Wage Committee met several times to review and update pay rates for blue-collar workers in different areas. These changes affect DoD employees paid from government funds and could impact their wages soon. The meetings were private and focused on making sure pay stays fair and up-to-date.
Next: 2026-04861 — Notice of Continuation and Request for Applications for the Industry Trade Advisory Committees
The U.S. government is renewing the Industry Trade Advisory Committees (ITACs) for another four years and is looking for new members to join. If you’re interested in helping shape trade policies and agreements, apply by April 2, 2026. This is a great chance for qualified folks to influence important trade decisions and be part of a key advisory team.